发明名称 Hydrogel-driven layered drug dosage form
摘要 A controlled release dosage form for sertraline has a core comprising a sertraline-containing composition and a water-swellable composition wherein the water-swellable composition is in a separate region within the core. A coating around the core is water-permeable, water-insoluble, and has at least one delivery port therethrough. In one embodiment, the dosage form releases sertraline to the use environment at an average rate of 6 to 10 wt % per hour from the second to the twenth hour after introduction to a use environment and less than about 25 wt % for the first two hours and at least 70 wt % by the twelfth hour, where the percentages correspond to the mass of drug released from the tablet divided by the total mass of drug originally present in the tablet. In another embodiment, the dosage form releases less than about 25 wt % of sertraline to the use environment by the second hour after introduction of the dosage form to the use environment, and delivers at least 25 wt % from the eighth to the twenty-fourth hour.
申请公布号 AU1724301(A) 申请公布日期 2001.07.09
申请号 AU20010017243 申请日期 2000.12.13
申请人 PFIZER PRODUCTS INC. 发明人 WILLIAM JOHN CURATOLO;MICHAEL BRUCE FERGIONE;MICHAEL CHRISTOPHER ROY;AVINASH GOVIND THOMBRE;KENNETH CRAIG WATERMAN;LEAH ELIZABETH APPEL;RONALD ARTHUR BEYERINCK;MARK BRIAN CHIDLAW;DWAYNE THOMAS FRIESEN;DANIELLE SUPPLEE
分类号 A61K9/26;A61K9/00;A61K9/22;A61K9/36;A61K31/135;A61K47/10;A61K47/12;A61K47/26;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61P3/04;A61P15/00;A61P15/10;A61P25/20;A61P25/22;A61P25/24;A61P25/30;A61P43/00 主分类号 A61K9/26
代理机构 代理人
主权项
地址